✦ For YouGeopoliticsTechFinanceHealthEnergySportsCulture◆ SN Last Week★ Saved

Health·Updated hourly·1,983 stories

Health News Summary Today — Page 24

Medical breakthroughs, public health and scientific discoveries — quick news summary

Triple-action diabetes jab shown to reduce blood sugar and body weight

Triple-action diabetes jab shown to reduce blood sugar and body weight

A phase‑3 trial of Eli Lilly’s weekly triple‑hormone drug retatrutide in 930 adults with type 2 diabetes showed that participants lost up to 15 % of body weight and cut HbA1c by nearly 2 % after 40 we

The Guardian Science · 24d ago
Ancient Chinese medicine could transform hair loss treatment

Ancient Chinese medicine could transform hair loss treatment

A new scientific review highlights the traditional Chinese root Polygonum multiflorum as a multi‑target candidate for treating androgenetic alopecia. The herb, used for more than a millennium, may blo

Science Daily · 24d ago
Daraxonrasib nearly doubles pancreatic cancer survival

Daraxonrasib nearly doubles pancreatic cancer survival

Daraxonrasib, a daily pill that blocks malfunctioning RAS proteins, nearly doubled median survival to 13 months in a 500-patient Phase III trial of advanced pancreatic cancer, outperforming standard c

SkimNews · 25d ago
STAT's ADA newsletter provides day‑2 conference recap

STAT's ADA newsletter provides day‑2 conference recap

STAT’s ADA in 30 Seconds newsletter delivers a day‑2 recap of the American Diabetes Association annual conference. The full article and premium analysis are exclusive to STAT+ subscribers, who can sig

STAT News · 25d ago
Retatrutide Linked to Arrhythmias, Cardio Risks

Retatrutide Linked to Arrhythmias, Cardio Risks

Eli Lilly presented new safety data for its next‑generation obesity drug, retatrutide, at the American Diabetes Association meeting. In the TRANSCEND‑T2D‑1 trial, 7 of 403 participants on retatrutide

STAT News · 25d ago
GLP‑1 Weight‑Loss Drugs Linked to 30% Lower Breast

GLP‑1 Weight‑Loss Drugs Linked to 30% Lower Breast

A study of over 110,000 women found that users of GLP‑1 medications—including Ozempic, Wegovy, Mounjaro, and Zepbound—had about a 30% lower risk of developing breast cancer. The observational findings

Science Daily · 25d ago
STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential

STAT+: Detailed data show Pfizer’s monthly obesity drug continues to show potential

Pfizer’s obesity drug berobenatide, acquired from Metsera, was tested in the VESPER‑3 mid‑stage trial where patients switched from weekly to higher monthly doses. Those who remained on treatment lost

STAT News · 25d ago
The supplements older adults actually need and the ones they don't

The supplements older adults actually need and the ones they don't

Older adults are increasingly using dietary supplements, yet many offer little benefit unless a specific deficiency exists. The article highlights that low vitamin B12, vitamin D, protein, and folate

Science Daily · 25d ago
JAMA Review Finds Diagnostic Interviews Less Reliable

JAMA Review Finds Diagnostic Interviews Less Reliable

A new JAMA Network Open review of diagnostic interviews from February 2024 to September 2025 found that test‑retest reliability varies across mental‑health conditions, with substance‑use disorders—esp

The Guardian Science · 25d ago
Free‑living amoebae pose health risk, study warns

Free‑living amoebae pose health risk, study warns

Scientists warn that free‑living amoebae, microbes found in water and soil, are an underappreciated public‑health risk capable of causing deadly infections and shielding other pathogens. The brain‑eat

Science Daily · 25d ago
First Opinion Podcast Explores Amish Views on Vaccines

First Opinion Podcast Explores Amish Views on Vaccines

The First Opinion Podcast hosts a conversation with medical researchers Braxton Mitchell and Cory Anderson about the Amish, public health, and vaccine attitudes. The hosts explain that the Amish are a

STAT News · 25d ago
Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference

Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference

At a US cancer conference, researchers presented new oral and combination therapies that overcome tumor immune evasion and improve outcomes. The tablet GRWD5769 plus cemiplimab shrank tumours in 26 of

The Guardian Science · 25d ago
STAT+: Newer GLP-1s, pushback on research cuts, and a protest

STAT+: Newer GLP-1s, pushback on research cuts, and a protest

STAT+ launches its first ADA in 30 Seconds newsletter from the American Diabetes Association’s annual conference in New Orleans. Editor Elizabeth Cooney introduces the briefing, highlighting upcoming

STAT News · 26d ago
Columbia Study Shows Base Editing Edits Embryos Safely

Columbia Study Shows Base Editing Edits Embryos Safely

Recent research shows CRISPR base editing can modify healthy human embryos without the unwanted mutations that plagued earlier CRISPR‑Cas9 approaches. A Columbia study led by Dieter Egli achieved prec

New Scientist · 26d ago
SETI Updates Alien Signal Verification Protocols

SETI Updates Alien Signal Verification Protocols

The International Academy of Astronautics has published updated protocols for how SETI researchers should verify, announce, and manage potential signals from intelligent alien civilizations, replacing

The Guardian Science · 26d ago
🧬

Launch HN: General Instinct (YC P26) – Frontier models on edge devices

General Instinct, a robotics‑focused startup, open‑sourced its InstinctRazor toolkit and demonstrated that the 245 GB BF16 MoE model Qwen3.5‑122B‑A10B can be compressed to a 48 GiB GGUF while preservi

Hacker News · 26d ago
Cambridge AI Coronavirus Vaccine Passes Human Trial

Cambridge AI Coronavirus Vaccine Passes Human Trial

Scientists at the University of Cambridge and spinout DIOSynVax have completed a Phase I trial of an AI‑designed universal coronavirus vaccine in 39 healthy volunteers. The vaccine was safe, well tole

Science Daily · 26d ago
Genetic variants cause 10% resistance to Ozempic

Genetic variants cause 10% resistance to Ozempic

A Stanford‑led international study identified genetic variants that render about 10% of people less responsive to GLP‑1 receptor agonists such as Ozempic. Carriers of these variants showed poorer bloo

Science Daily · 26d ago
Japan Team Inserts Rat Chromosome into Mouse Embryos

Japan Team Inserts Rat Chromosome into Mouse Embryos

Japanese researchers at Yamanashi University have inserted a deep‑frozen rat chromosome into mouse embryos, producing chimeric mice and demonstrating a new way to study extinct‑animal genes in living

New Scientist · 26d ago
Anglia Ruskin study finds collagen boosts skin, joints

Anglia Ruskin study finds collagen boosts skin, joints

The largest meta‑analysis of collagen supplements, led by Anglia Ruskin University, pooled data from 16 systematic reviews, 113 randomized trials and nearly 8,000 participants. It found that regular c

Science Daily · 26d ago

Get the Health newsletter

Curated health stories, every morning. Free.

No spam. Unsubscribe anytime.